RxDoctor Payments DataLook up a doctor →

Damon Travis, DO

Family Medicine · Harrisonville, MONPI 1578583852

Payments from drug & device makers

$19,307in general payments, 2019–2025

Across 1,175 payments — averaging $16.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$3K
  • AstraZeneca$2K
  • Amgen$2K
  • Novo Nordisk$1K
  • Pfizer$1K
  • Johnson & Johnson$775
  • plus $10K from 54 others

What the payments were for

  • Food & beverage$19,17599%
  • Education$1321%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)214$2,742
AstraZeneca(2 entities)77$1,880
Amgen72$1,579
Novo Nordisk111$1,368
Pfizer103$1,190
Johnson & Johnson34$775
Lilly USA, LLC40$578
Otsuka America Pharmaceutical, Inc.43$538
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)19$536
GSK38$517
Abbott20$453
Novartis43$448
Merck25$444
Sanofi-aventis U.S. LLC30$428
QOL Medical, LLC15$410
Bayer10$357
Dexcom, Inc.23$337
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC19$308
Boehringer Ingelheim19$293
Kowa Pharmaceuticals America, Inc.12$265
Astellas Pharma US Inc9$215
Takeda Pharmaceuticals U.S.A., Inc.15$207
Shield Therapeutics Inc5$204
Sunovion Pharmaceuticals Inc.12$192
Biohaven Pharmaceutical Holding Company Ltd.12$183
Teva Pharmaceuticals USA, Inc.12$176
Vanda Pharmaceuticals Inc.7$167
Daiichi Sankyo Inc.8$162
Medtronic(2 entities)3$161
Amarin Pharma, Inc.9$149
Axsome Therapeutics, Inc.8$140
Corcept Therapeutics6$139
Collegium Pharmaceutical, Inc.9$138
Lundbeck LLC5$134
Eisai Inc.8$126
Ardelyx, Inc.5$118
Mylan Specialty L.p.6$98
Ironwood Pharmaceuticals, Inc6$93
Biohaven Pharmaceuticals, Inc.5$80
Corium, LLC3$76
Arbor Pharmaceuticals, Inc.5$70
Ferring Pharmaceuticals Inc.3$70
Esperion Therapeutics, Inc.4$67
Shire North American Group Inc4$66
Antares Pharma, Inc.4$63
Vertex2$45
E.r. Squibb & Sons, L.L.C.3$44
Adlon Therapeutics L.p.3$40
Protega Pharmaceutials Inc2$35
Phathom Pharmaceuticals, Inc.2$34
Radius Health, Inc.1$27
Globus Medical1$26
Currax Pharmaceuticals LLC2$26
Nevro Corp.1$25
Regeneron Healthcare Solutions, Inc.1$25
Lexicon Pharmaceuticals, Inc.1$24
Boston Scientific1$24
Agile Therapeutics, Inc.1$20
Sumitomo Pharma America, Inc.2$19
Azurity Pharmaceuticals, Inc.1$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$19,307 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$86,449
Medicare patients
397
Services billed
1,080

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide231$284,464
EliquisApixaban305$277,720
FarxigaDapagliflozin Propanediol258$236,116
JardianceEmpagliflozin194$173,546
XareltoRivaroxaban114$89,293
MounjaroTirzepatide79$87,766
ProliaDenosumab33$58,285
Xtampza ErOxycodone Myristate60$50,612
MyrbetriqMirabegron65$43,986
Trelegy ElliptaFluticasone/Umeclidin/Vilanter46$41,368
Tresiba Flextouch U-100Insulin Degludec49$38,594
TrulicityDulaglutide27$35,850
RexultiBrexpiprazole18$33,906
LinzessLinaclotide38$32,311
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog33$31,284

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$1,368$299,745244 claims
PfizerEliquis$1,190$277,720305 claims
AstraZenecaFarxiga, Breztri Aerosphere, Bevespi Aerosphere$1,880$269,918305 claims
Boehringer IngelheimJardiance, Trijardy Xr$293$180,758206 claims
Lilly USA, LLCMounjaro, Trulicity$578$123,616106 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$517$96,478151 claims
Johnson & JohnsonXarelto$775$89,293114 claims
AmgenProlia$1,579$58,28533 claims
Collegium Pharmaceutical, Inc.Xtampza Er$138$50,61260 claims
Astellas Pharma US IncMyrbetriq$215$43,98665 claims
MerckJanuvia, Belsomra$444$36,38965 claims
Otsuka America Pharmaceutical, Inc.Rexulti$538$33,90618 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Harrisonville

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →